regn5459, a bcma×cd3 bispecific antibody, in r/r multiple myeloma
Published 1 year ago • 151 plays • Length 5:28
Download video MP4
Download video MP3
Similar videos
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
3:30
sc vs. iv administration of a bcma-cd3 bispecific antibody for r/r myeloma
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
2:44
dual-targeting bispecific antibody alnuctamab in r/r multiple myeloma
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
43:39
antigen presentation, t cell activation and deactivation
-
1:40
multiple myeloma: early diagnosis and treatment │ dr. balkrishna padate│nanavati max, mumbai
-
5:00
rouleaux formation | peripheral blood smear examination | hematology | multiple myeloma| esr |
-
2:02
alnuctamab, a bcma x cd3 tce, in the treatment of multiple myeloma
-
1:29
bispecific bcma-cd3 antibody teclistamab is efficacious and tolerable in r/r mm
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
3:41
teclistamab: bcma x cd3 bispecific antibody in rrmm
-
1:10
the importance of bcma, fcrh5 and gprc5d in multiple myeloma
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
1:56
bfcr4350a: a novel bispecific antibody in r/r myeloma therapy
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
4:45
a first-in-human trial of regn5458 in r/r myeloma: updated phase i data
-
1:45
using the available repertoire of bispecific antibodies for treating multiple myeloma
-
2:32
updates on the use of melflufen in r/r multiple myeloma
Clip.africa.com - Privacy-policy